GSK at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
GSK takes part in 4 sessions at BioTechX Europe 2026 in Basel. Its sessions cover AI agents in R&D, putting digital tools to practical use, and real-world evidence, meaning data from routine patient care, for rare diseases. One topic links written reports, data and a record of where each dataset came from to answer key questions.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
GSK London, UK | |
Global biopharmaceutical company developing vaccines and specialty medicines. | Keynote Tue Oct 6 09:40 The use of agentic AI in R&D AI & large language models Panel Wed Oct 7 16:30 Talk Thu Oct 8 11:10 Beyond the Document: Joining narrative, data and lineage to answer our most critical questions Why submissions to regulators should be built from reusable blocks of text and data, since 40 to 70% of content repeats across studies. Talk Thu Oct 8 11:10 |
Instantly find 20 buyers from GSK
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction